TickerFacts.

Spectral AI, Inc. (MDAI): Revenue

Annual figures by period end, from SEC filings.

$19.65M
Year ended 2025-12-31
$15.39M
Trailing 12 months to 2026-06-30
-8.2%
3-year compound annual growth
$29.58M2022-12-31: $25.37M2023-12-31: $18.06M2024-12-31: $29.58M2025-12-31: $19.65M$19.65M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$19.65M-33.6%2026-03-25, From 2025-01-01
2024-12-31$29.58M+63.8%2026-03-25, From 2024-01-01
2023-12-31$18.06M-28.8%2025-03-31, From 2023-01-01
2022-12-31$25.37Mn/a2024-03-29, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Spectral AI, Inc. (MDAI)2025-12-31$19.65M-33.6%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$19.53M+36.7%
Nephros Inc (NEPH)2025-12-31$18.79M+32.7%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$17.44M+16.0%
DarioHealth Corp. (DRIO)2025-12-31$22.36M-17.3%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$22.54M-39.2%
Profound Medical Corp. (PROF)2025-12-31$16.10M+50.7%
Biotricity Inc. (BTCY)2026-03-31$16.00M+16.0%
Allurion Technologies, Inc. (ALUR)2025-12-31$15.23M-52.6%

Compare MDAI, SNOA, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗